Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
134.97%
↑ 1164% above average
Average (9y)
-12.68%
Historical baseline
Range
High:134.97%
Low:-121.91%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 134.97% |
| 2023 | 13.34% |
| 2022 | 20.83% |
| 2021 | -86.77% |
| 2020 | -30.39% |
| 2019 | 54.49% |
| 2018 | -21.07% |
| 2017 | -121.91% |
| 2016 | -52.18% |
| 2015 | -38.14% |